Clinical Trial Update: A Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's Disease

View source ↗

Summary

Amoneta Diagnostics SAS reports completion of a clinical trial evaluating a biomarker-chip assay in preserved red blood cells for diagnosing Alzheimer's disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia
• Frontotemporal Dementia

Snippet

Sponsor: Amoneta Diagnostics SAS | Conditions: Alzheimer's Disease (AD), Neurodegenerative Disease | Status: COMPLETED